Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Delivery Prior to Implantation of a Posterior Chamber IOL

NCT01602068 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract

Interventions

DRUG: Dexamethasone Phosphate Ophthalmic
DRUG: 100 mM Sodium Citrate Buffer

Sponsor

Eyegate Pharmaceuticals, Inc.